Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for SRx Health Solutions (SRXH) over the last 14 years, with Q3 2025 value amounting to $1.4 million.

  • SRx Health Solutions' Accumulated Expenses fell 2587.6% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 2587.6%. This contributed to the annual value of $1.4 million for FY2025, which is N/A changed from last year.
  • SRx Health Solutions' Accumulated Expenses amounted to $1.4 million in Q3 2025, which was down 2587.6% from $3.2 million recorded in Q2 2025.
  • In the past 5 years, SRx Health Solutions' Accumulated Expenses ranged from a high of $3.2 million in Q2 2025 and a low of $1.4 million during Q2 2024
  • Its 5-year average for Accumulated Expenses is $2.0 million, with a median of $1.9 million in 2021.
  • Per our database at Business Quant, SRx Health Solutions' Accumulated Expenses tumbled by 7008.01% in 2021 and then skyrocketed by 13813.37% in 2025.
  • SRx Health Solutions' Accumulated Expenses (Quarter) stood at $1.9 million in 2021, then soared by 38.16% to $2.6 million in 2022, then dropped by 19.68% to $2.1 million in 2023, then decreased by 26.38% to $1.5 million in 2024, then fell by 10.42% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q3 2025, $3.2 million for Q2 2025, and $1.6 million during Q1 2025.